Autolus Therapeutics Plc (AUTL)
2.31
-0.04
(-1.70%)
USD |
NASDAQ |
Sep 01, 16:00
2.30
-0.01
(-0.43%)
After-Hours: 04:03
Autolus Therapeutics Cash from Operations (Annual) : -284.23M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -284.23M |
| December 31, 2024 | -206.36M |
| December 31, 2023 | -145.59M |
| December 31, 2022 | -112.24M |
| December 31, 2021 | -117.86M |
| Date | Value |
|---|---|
| December 31, 2020 | -117.76M |
| December 31, 2019 | -101.48M |
| September 30, 2018 | -31.54M |
| September 30, 2017 | -16.36M |
| September 30, 2016 | -9.849M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Bicycle Therapeutics Plc | -250.26M |
| Biodexa Pharmaceuticals Plc | -7.268M |
| argenx SE | 850.49M |
| NuCana Plc | -9.377M |
| Mereo BioPharma Group Plc | -31.04M |